These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 9271340
1. An efficacy-dependent effect of cardiac overexpression of beta2-adrenoceptor on ligand affinity in transgenic mice. Gürdal H, Bond RA, Johnson MD, Friedman E, Onaran HO. Mol Pharmacol; 1997 Aug; 52(2):187-94. PubMed ID: 9271340 [Abstract] [Full Text] [Related]
2. Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2-adrenoceptor activation. Nagaraja S, Iyer S, Liu X, Eichberg J, Bond RA. Br J Pharmacol; 1999 Jul; 127(5):1099-104. PubMed ID: 10455254 [Abstract] [Full Text] [Related]
4. Chronic infusion of beta-adrenoceptor antagonist and inverse agonists decreases elevated protein kinase A activity in transgenic mice with cardiac-specific overexpression of human beta 2-adrenoceptor. Liu X, Callaerts-Vegh Z, Evans KL, Bond RA. J Cardiovasc Pharmacol; 2002 Sep; 40(3):448-55. PubMed ID: 12198331 [Abstract] [Full Text] [Related]
7. Monovalent anions differentially modulate coupling of the beta2-adrenoceptor to G(s)alpha splice variants. Seifert R. J Pharmacol Exp Ther; 2001 Aug; 298(2):840-7. PubMed ID: 11454950 [Abstract] [Full Text] [Related]
8. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling. Molenaar P, Savarimuthu SM, Sarsero D, Chen L, Semmler AB, Carle A, Yang I, Bartel S, Vetter D, Beyerdörfer I, Krause EG, Kaumann AJ. Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024 [Abstract] [Full Text] [Related]
9. Profile of ligand binding to the porcine beta2-adrenergic receptor. Liang W, Mills S. J Anim Sci; 2001 Apr; 79(4):877-83. PubMed ID: 11325192 [Abstract] [Full Text] [Related]
12. Restricting mobility of Gsalpha relative to the beta2-adrenoceptor enhances adenylate cyclase activity by reducing Gsalpha GTPase activity. Wenzel-Seifert K, Lee TW, Seifert R, Kobilka BK. Biochem J; 1998 Sep 15; 334 ( Pt 3)(Pt 3):519-24. PubMed ID: 9729456 [Abstract] [Full Text] [Related]
13. Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers. Lavoie C, Hébert TE. Can J Physiol Pharmacol; 2003 Feb 15; 81(2):186-95. PubMed ID: 12710533 [Abstract] [Full Text] [Related]
14. G protein, phosphorylated-GATA4 and VEGF expression in the hearts of transgenic mice overexpressing β1- and β2-adrenergic receptors. Tae HJ, Petrashevskaya N, Kim IH, Park JH, Lee JC, Won MH, Kim YH, Ahn JH, Park J, Choi SY, Jeon YH. Mol Med Rep; 2017 Jun 15; 15(6):4049-4054. PubMed ID: 28487987 [Abstract] [Full Text] [Related]
15. Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library. Ahn S, Kahsai AW, Pani B, Wang QT, Zhao S, Wall AL, Strachan RT, Staus DP, Wingler LM, Sun LD, Sinnaeve J, Choi M, Cho T, Xu TT, Hansen GM, Burnett MB, Lamerdin JE, Bassoni DL, Gavino BJ, Husemoen G, Olsen EK, Franch T, Costanzi S, Chen X, Lefkowitz RJ. Proc Natl Acad Sci U S A; 2017 Feb 14; 114(7):1708-1713. PubMed ID: 28130548 [Abstract] [Full Text] [Related]
16. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. Seifert R, Wenzel-Seifert K, Lee TW, Gether U, Sanders-Bush E, Kobilka BK. J Biol Chem; 1998 Feb 27; 273(9):5109-16. PubMed ID: 9478963 [Abstract] [Full Text] [Related]
17. Computational study on the different ligands induced conformation change of β2 adrenergic receptor-Gs protein complex. Bai Q, Zhang Y, Ban Y, Liu H, Yao X. PLoS One; 2013 Feb 27; 8(7):e68138. PubMed ID: 23922653 [Abstract] [Full Text] [Related]
19. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. Zhu WZ, Chakir K, Zhang S, Yang D, Lavoie C, Bouvier M, Hébert TE, Lakatta EG, Cheng H, Xiao RP. Circ Res; 2005 Aug 05; 97(3):244-51. PubMed ID: 16002745 [Abstract] [Full Text] [Related]
20. β-blockade abolishes the augmented cardiac tPA release induced by transactivation of heterodimerised bradykinin receptor-2 and β2-adrenergic receptor in vivo. Aspelin T, Eriksen M, Ilebekk A, Cataliotti A, Carlson CR, Lyberg T. Thromb Haemost; 2014 Nov 05; 112(5):951-9. PubMed ID: 25078038 [Abstract] [Full Text] [Related] Page: [Next] [New Search]